Sandoz unit Lek Pharmaceuticals can get EUR52 million in Slovenian aid
MLex Summary: Lek Pharmaceuticals, a company of the Sandoz group, can receive around 52 million euros in Slovenian aid for the construction of a high-tech plant to produce biological drug substances...To view the full article, register now.
Already a subscriber? Click here to view full article